Gottlieb, A., P. Gisondi, J. Eells, L. Peterson, and A. Kavanaugh. “Durability of Response in Patients With Psoriatic Arthritis Treated With Certolizumab Pegol over 216 Weeks: Post-Hoc Analyses from the RAPID-PsA Study”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 1, Jan. 2020, p. S2, https://jofskin.org/33014/index.php/skin/article/view/801.